Cancer Genetics - 16.02.26
Overview of Non-Medical Skin Cancer and Genetics
Introduction to non-medical skin cancer based on carcinomas.
Description of normal cell growth controlled by a series of genes.
Genetic Alterations
Genetic alterations in cell growth operate via cytotoxic gene functions.
The alteration occurs in only one cell within the body, although it is prevalent across various individuals.
Most genetic alterations are somatic mutations occurring in normal body cells rather than hereditary mutations.
Somatic mutations are mutations acquired during a person's lifetime that are not passed down to offspring.
A small percentage (~5-10%) of cancers are hereditary, with gene alterations present in all cells of the body from conception.
Types of Gene Mutations
Somatic Mutations: Predominantly acquired and specific to certain tissues.
Example: Mutations in breast tissue leading to breast cancer.
Hereditary Mutations: Consist of genetically altered cells present in every cell of an individual's body.
May derive from the parental germ line (sperm or egg).
Risk of Hereditary Cancer
Hereditary cancer syndromes arise when multiple family members are affected by cancer.
Increased risk of hereditary cancer is suggested by:
Early onset of cancer (e.g., bowel cancer diagnosed in one’s 40s versus the average age of 60-70).
Having multiple primary cancers (e.g., a person with both lung and bone cancers).
Characteristics of syndromes that increase likelihood of hereditary cancer:
Family history of cancer;
Occurrence of the same type of cancer in close relatives.
Genetic Testing and Screening
Genetic testing is focused on assessing the risk rather than performing routine testing for everyone.
Screening and prevention strategies might include:
Risk assessment based on family history.
Genetic counseling for at-risk families.
Medical follow-up is important for individuals at high risk of hereditary cancer but is different for those without increased risk.
Classification of Hereditary Cancers
Two major classifications:
Based on the type of tumor clinically observed.
Based on the type of genes altered:
Tumor Suppressor Genes: Normally, genes that act to slow down cell growth.
Oncogenes: Promote cell growth; mutations can lead to overactivity and uncontrolled cell proliferation.
DNA Damage Response Genes: Involved in DNA repair, critical for maintaining genomic stability.
Detailed Overview of Gene Types
Tumor Suppressor Genes:
Function to slow down and control cell division. Both copies of a tumor suppressor gene must be inactivated to lead to uncontrolled growth.
Examples of alterations and their impacts:
Loss of Function: Requires two 'hits' or mutations for expression of cancer; often hereditary in nature.
Example: Retinoblastoma occurs due to inherited mutations leading to earlier onset and bilateral cancer.
Oncogenes:
Normal roles are to promote cell division; mutations can activate them excessively leading to uncontrolled growth.
Only one mutation needed to activate oncogenes significantly.
Genes Involved in DNA Repair:
Repair mechanisms correct DNA replication errors to maintain genomic integrity.
Faulty repair can lead to accumulation of mutations.
Example: Lynch Syndrome results from repair gene defects, increasing colon cancer risk.
Penetrance and Hereditary Cancer
Penetrance refers to the proportion of individuals with a specific genetic alteration that express the corresponding condition.
Incomplete penetrance exists when not all carriers of germline alterations develop cancer.
Example: A person with a faulty gene may never develop cancer, leading to genealogical skips in cancer prevalence.
Example Family Cascade for Hereditary Cancer
Visual example of a family tree to illustrate inheritance of a condition like breast cancer.
Symbols:
Squares represent males, circles represent females.
Horizontal lines denote mating lines; children are shown below.
Hereditary Non-Polyposis Colorectal Cancer (Lynch Syndrome)
Identified by lack of DNA repair, leading to instability in tumors.
Associated with additional cancers (e.g., endometrial cancer) and mismatch repair genes.
Clinical Implications
Understanding cancer genetics is crucial for developing tailored screening and prevention strategies.
Family dynamics and ancestry play a vital role in recognizing risk factors for hereditary cancer syndromes.
Conclusion
Early detection and intervention strategies are critical in managing hereditary cancer risks.
Genetic predispositions vary among families, demanding personalized approaches for testing and screening that consider family history and individual characteristics.